Kiromic BioPharma, Inc. (KRBP)
| Market Cap | 5.88M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -29.10M |
| Shares Out | 15.84M |
| EPS (ttm) | -2.18 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 100,801 |
| Open | 0.365 |
| Previous Close | 0.370 |
| Day's Range | 0.365 - 0.394 |
| 52-Week Range | 0.230 - 4.600 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 11, 2022 |
About KRBP
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candidate targeting PD-L1. It has license agreements with CGA 369 Intellectual Holdings, Inc. and Longwoo... [Read more...]
Financial Performance
Financial StatementsNews
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses of $100,000...
LOS ANGELES--(BUSINESS WIRE)---- $KRBP #KRBP--The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses of $100,000 to Contact the Firm
Kiromic BioPharma Appoints Leonardo Mirandola, Ph.D. as Chief Scientific Officer
HOUSTON--(BUSINESS WIRE)---- $KRBP #CART--Kiromic BioPharma, Inc. (NASDAQ: KRBP) (“Kiromic” or the “Company”), a clinical-stage fully integrated biotherapeutics company using its proprietary DIAMOND® ar...
Why Kiromic BioPharma Shares Are Trading Higher Today?
Kiromic BioPharma Inc (NASDAQ: KRBP) has completed the construction of its expanded current good manufacturing practice manufacturing facility in Houston. The expanded facility located at Kiromic's head...
Top Penny Stocks To Buy Today? 3 To Watch Under $3
Top penny stocks to watch this week. The post Top Penny Stocks To Buy Today?
Kiromic BioPharma Achieves Milestone with Timely Completion of Expanded cGMP Manufacturing Facility to Support Cell T...
HOUSTON--(BUSINESS WIRE)-- #CART--Kiromic BioPharma, Inc. (NASDAQ: KRBP) (“Kiromic” or the “Company”), a clinical-stage fully integrated biotherapeutics company using its proprietary DIAMOND® artificial...
Kiromic BioPharma's Prioritizes New Gamma Delta T-Cell Product Candidate
Kiromic BioPharma Inc (NASDAQ: KRBP) has announced a strategic pipeline shift to prioritize its allogeneic, non-engineered off-the-shelf product candidate, Deltacel/KB-GDT. Kiromic expects to submit its...
Kiromic BioPharma Pipeline to Prioritize a New Gamma Delta T-cell Product Candidate
HOUSTON--(BUSINESS WIRE)--Kiromic BioPharma, Inc. (NASDAQ: KRBP), a clinical-stage biotherapeutics company using its proprietary DIAMOND AI® (artificial intelligence) and data mining platform to discove...
Halted Stocks: 9 Circuit Breaker Stocks That Have Been Halted on Tuesday
We've seen a large array of halted stocks today as circuit breakers take effect to reign in unexpected volatility for some shares. The post Halted Stocks: 9 Circuit Breaker Stocks That Have Been Halted ...
Why Is Kiromic BioPharma (KRBP) Stock Up 75% Today?
Kiromic BioPharma (KRBP) stock is rocketing higher on Tuesday following announcing a new sponsored research agreement (SRA). The post Why Is Kiromic BioPharma (KRBP) Stock Up 75% Today?
Why Kiromic Biopharma Shares Are Skyrocketing Today
Kiromic Biopharma Inc (NASDAQ: KRBP) shares are trading higher by 78.5% at $0.50 after the company entered a Sponsored Research Agreement (SRA) under which in vivo preclinical data will be generated fro...
Kiromic BioPharma Significantly Expands Gamma Delta T cell Product Pipeline with New Sponsored Research Agreement
HOUSTON--(BUSINESS WIRE)--Kiromic BioPharma Significantly Expands Gamma Delta T cell Product Pipeline with New Sponsored Research Agreement
Kiromic BioPharma Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
HOUSTON--(BUSINESS WIRE)--Kiromic BioPharma, Inc. (NASDAQ: KRBP) (“Kiromic” or the “Company”), a clinical-stage fully integrated biotherapeutics company using its proprietary DIAMOND® artificial intelli...
Kiromic BioPharma Announces Company Will Directly Submit Amended IND for Procel™ to the FDA in Second Half of 2022
HOUSTON--(BUSINESS WIRE)--Kiromic BioPharma, Inc. (NASDAQ: KRBP) (“Kiromic” or the “Company”), a clinical-stage fully integrated biotherapeutics company using its proprietary DIAMOND® artificial intelli...
10 Top Penny Stocks To Buy For Under $1 May 2022 Edition
Top penny stocks under $1 to watch in May. The post 10 Top Penny Stocks To Buy For Under $1 May 2022 Edition appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Kiromic BioPharma Announces Availability of Company's Current Corporate Presentation
HOUSTON--(BUSINESS WIRE)--Kiromic BioPharma, Inc. (NASDAQ: KRBP) (“Kiromic” or the “Company”), a clinical-stage fully integrated biotherapeutics company using its proprietary DIAMOND AI® (artificial int...
Kiromic BioPharma Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Corporate Highlights
HOUSTON--(BUSINESS WIRE)--Kiromic BioPharma, Inc. (NASDAQ: KRBP) (“Kiromic” or the “Company”), a clinical-stage fully integrated biotherapeutics company using its proprietary DIAMOND® artificial intelli...
Kiromic Biopharma Announces Filing of Form 12b-25
HOUSTON--(BUSINESS WIRE)--Kiromic BioPharma, Inc. (NASDAQ: KRBP) (“Kiromic” or the “Company”), a clinical-stage fully integrated biotherapeutics company using its proprietary DIAMOND® artificial intelli...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Kiromic BioPharma, Inc. (KRBP) Investors to Investigation of Possible...
San Francisco, California--(Newsfile Corp. - March 31, 2022) - Hagens Berman urges Kiromic BioPharma, Inc. (NASDAQ: KRBP) investors who purchased Kiromic shares to submit your losses now. The firm is in...
Kiromic BioPharma Provides Business Update and Reports Third Quarter 2021 Financial Results
HOUSTON--(BUSINESS WIRE)---- $KRBP #KRBP--Kiromic BioPharma Provides Business Update and Reports Third Quarter 2021 Financial Results
4 Top Penny Stocks To Buy For Under $1 This Week
Penny stocks to watch under $1 this week. The post 4 Top Penny Stocks To Buy For Under $1 This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Kiromic BioPharma Announces Changes in Management, Board of Directors
HOUSTON--(BUSINESS WIRE)---- $KRBP #KRBP--Kiromic BioPharma Announces Changes in Management, Board of Directors
Kiromic BioPharma Appoints Frank Tirelli and Dr. Karen Reeves to Company's Board of Directors
HOUSTON--(BUSINESS WIRE)---- $KRBP #KRBP--Kiromic BioPharma Appoints Frank Tirelli and Dr. Karen Reeves to Company's Board of Directors
Kiromic BioPharma Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
HOUSTON--(BUSINESS WIRE)---- $KRBP #KRBP--Kiromic BioPharma Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
Kiromic BioPharma, Now Clinical Stage, Reports Significant Progression Free Survival Benefit in Metastatic Pancreatic...
HOUSTON--(BUSINESS WIRE)---- $KRBP #KRBP--Kiromic, Now Clinical Stage, Reports Significant Progression Free Survival Benefit in Metastatic Pancreatic Cancer Patient Treated with KiroVax/BSK01
Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allo...
HOUSTON--(BUSINESS WIRE)---- $KRBP #KRBP--Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital